Related Experiment Videos

Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?

Brady L Stein^1,2, Srdan Verstovsek³

¹Division of Hematology-Oncology, Department of Medicine, Chicago, IL, 60611, USA. Brady.Stein@nm.org.

Current Hematologic Malignancy Reports

|October 17, 2017

Abstract:

ᅟ.

Keywords:

Myeloproliferative neoplasm Polycythemia vera Prognosis

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.

Blood·2023

A safe and effective use of caplacizumab in pregnancy-related acquired thrombotic thrombocytopenic purpura.

British journal of haematology·2023

JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple options.

Leukemia & lymphoma·2022

Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2022

Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials.

Current hematologic malignancy reports·2021

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2020

See all related articles